PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 1/22

Are We Having Fun Yet?

PharmD_KS's avatar
PharmD_KS
Jan 21, 2026
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The 2026 Equity Markets Year Ahead can be watched here: 2026 Equity Markets Year Ahead

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 1/18

A pretty wild day in the market. In last night’s plan (subtitle “Target Met”) I suggested that my short term downside target had been met and included this same chart showing 6817.5-6821 was my downside target off a loss of 6908.5-6911. That range held all night and premarket and made for an amazing long right back to 6908.5-6911. The rejection there then made for an amazing short back down. However, bulls held a higher low with sellers finding little traction below 41.5-46 (key for today) before we got news of a bit of a Trump TACO (I guess) which saw an exaggerated move higher due to panicked short covering. This is the danger of messing around short near a major high time frame support (just like bulls learned that lesson early in the day long near 6908.5-6911).

We still have a bearish RTH gap overhead, and today’s move (for now) failed to sustain above the critical 6936-6940 reclaim. The daily is now in balance. There is currently a pattern of higher highs and higher lows but this daily balance along with the developing weekly profile matter more.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 PharmD_KS · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture